| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.36 | 3e-08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.31 | 1e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |